Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma-Reference-Cited by-同舟云学术

Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma

Published:2009-10-22 Issue:17 Volume:361 Page:1662-1670
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Perilongo Giorgio,Maibach Rudolf,Shafford Elisabeth,Brugieres Laurence,Brock Penelope,Morland Bruce,de Camargo Beatriz,Zsiros Jozsef,Roebuck Derek,Zimmermann Arthur,Aronson Daniel,Childs Margaret,Widing Eva,Laithier Veronique,Plaschkes Jack,Pritchard Jon,Scopinaro Marcello,MacKinlay Gordon,Czauderna Piotr

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0810613

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children’s hepatic tumors international collaboration database;eClinicalMedicine;2024-10

2. Effect of surgical complications on outcomes of children with hepatoblastoma: a retrospective cohort study;Surgery Today;2024-08-16

3. Successful treatment of young childhood standard‐risk hepatoblastoma with cisplatin monotherapy using a central review system;Pediatric Blood & Cancer;2024-08-10

4. Association of Sociodemographic Factors with Surgical Management of Hepatoblastoma and Hepatocellular Carcinoma in Children;The Journal of Pediatrics;2024-06

5. Successful Treatment of Refractory or Relapsed Hepatoblastoma With Autologous Hematopoietic Stem Cell Transplantation in Children;Journal of Pediatric Hematology/Oncology;2024-05-31